diabetic macular edema
Remote Ischemic Preconditioning and Diabetic Macular Edema
... This was a pilot single-blinded randomized controlled trial (RCT) to determine the effect of IPC on diabetic macular edema in patients referring to Yazd Diabetes Research Center. Inclusion criteria: ...
6
Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy
... [21]. Diabetic macular edema was defined as retinal thickening in the macular area of either eye, according to the ETDRS scale, and identified by optical coherence tomography (OCT) ...with ...
7
Critical appraisal of ranibizumab in the treatment of diabetic macular edema
... Abstract: Diabetic retinopathy is the leading cause of blindness among individuals of working age in industrialized nations, with most of the vision loss resulting from diabetic macular edema ...
11
<p>Retinal angiographic alteration in diabetic macular edema after dexamethasone implantation: a case report</p>
... Abstract: Here we reported a rare case of the implantation of a dexamethasone intravitreal implant (DEX) in which decreased retinal vessel density (VD) was found by optical coherence tomography angiography (OCTA). A ...
7
Subthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edema
... persistent macular edema and worsening of visual acuity on follow-up ...the macular area after maximum argon laser photocoagula- tion (Figure ...for diabetic macular edema that ...
7
Vitrectomy for center-involved diabetic macular edema
... in Diabetic Macular Edema Patients trial (clinical trials identifier #NCT02639507), a prospective, international, multicenter trial with standardized collection of VA and OCT data that is currently ...
8
Hospitalized cardiovascular events in patients with diabetic macular edema
... Diabetic macular edema (DME) may occur at any stage of diabetic retinopathy (DR) and is the leading cause of moderate vision loss in adults of working age ...
7
The clinical utility of aflibercept for diabetic macular edema
... center-involving diabetic macular edema (DME) has improved because of the proven efficacy of drugs that inhibit the effects of vascular endothelial growth factor ...for diabetic retinopathy in ...
10
Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
... 5. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase iii randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801. ...
7
The role of aflibercept in the management of diabetic macular edema
... Abstract: Diabetic macular edema (DME) represents one of the leading causes of visual impairment in working-age adults. Although there are several proven treatments available for this condition, ...
8
Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema
... for these patients. In a study from Wallick et al., patients with diabetic macular edema were found to have, on aver- age, 25.5 annual days with a health care related visit [6]. In a Canadian study ...
8
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
... Abstract: Diabetic macular edema (DME) has shown an increasing prevalence during the past years and is the leading cause of diabetic retinopathy ...
13
Intravitreal gas injection for the treatment of diabetic macular edema
... of diabetic macular edema is due to a complex interaction of a number of factors, and these include vitreoretinal relationships at the ...bate edema, while conversely a posterior vitreous ...
6
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
... Abstract: Diabetic macular edema (DME) resembles a chronic, low-grade inflammatory reac- tion, and is characterized by blood–retinal barrier (BRB) breakdown and retinal capillary ...in macular ...
15
Primary treatment of diabetic macular edema
... when edema affects the central retina or macula (diabetic macular edema, or ...DME). Macular edema is reversible in the early stages but chronic edema may lead to ...
8
Update on corticosteroids for diabetic macular edema
... Abstract: Diabetic macular edema (DME) remains an important cause of visual loss. Although anti-vascular endothelial growth factor (VEGF) agents are generally used as first-line treat- ments for ...
8
COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOWNLOAD/VIEW
... Diabetic macular edema (DME), is one of the most common causes of visual impairment in the diabetic patients ...of macular edema in patients with type 2 diabetes was up to 14%, ...
9
The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey
... Central macular thickness; CSME: Clinically significant macular edema; DCCT: Diabetes Control and Complications Trial; DIRECT: Diabetic Retinopathy Candesartan Trials; DME: Diabetic ...
8
Management of Refractory Diabetic Macular Edema: A Review Article
... to diabetic macular edema ...replacing macular laser photocoagulation as the standard treatment for DME; however, in some patients, incomplete responses to the anti-VEGF injection, defined as ...
8
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
... Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285 million people with diabetes mellitus worldwide, approximately one third have signs of DR and of these, a further one third ...
25